Clinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.
The TAVR-explant problem is now a number we can quote at heart team meetings. [NOTABLE] A narrative review of four studies and 35,677 patients pegs operative mortality of redo SAVR after TAVR at 12-17% versus 1.1-9% after prior SAVR , with propensity-matched odds ratios as high as 12.5 and observed-to-expected ratios exceeding 1.0 even in low-risk patients.
TAVR-SAVR volume is growing at up to 144.6% annually and may eclipse SAVR-SAVR by 2029.
STUDY OBJECTIVE: This study aimed to evaluate clinical outcomes of patients with symptomatic discordant (aortic stenosis) AS following transcatheter aortic valve replacement (TAVR). DESIGN: This is a retrospective cohort study. SETTING: Patients who underwent a TAVR for severe symptomatic native AS with preserved left ventricular ejection fraction ≥50% from 2012 to 2022 at our institution were included. PARTICIPANTS: Patients were divided into two cohorts, concordant AS (met all AS criteria) and discordant AS (< 3 criteria). INTERVENTIONS: TAVR. MAIN OUTCOMES MEASURES: The primary endpoint was all cause mortality and secondary outcomes were hospital readmissions for myocardial infarction (MI) and stroke. RESULTS: This study evaluated 2021 patients; the median age was 82.6 (77.0-87.2) years, and 53% were female. There was no difference in long-term mortality between discordant or concordant AS (HR: 0.89 [95% CI: 0.77-1.02]; P = 0.09). However, the discordant group had a higher 1-year mortality rate than the concordant group (14.5% vs 10.1%, respectively; P = 0.0054) and comparable mortality rates at 5 years (52.0% vs 50.5%, respectively; P = 0.18). The long-term readmission rate for MI was higher for the discordant group (HR: 0.47 [95% CI: 0.27-0.80]; P = 0.005), and there was no difference in readmission for stroke or transient ischemic attack (HR: 1.33 [95% CI: 0.92-1.94]; P = 0.133). CONCLUSIONS: Patients with symptomatic severe AS with discordant echocardiographic findings may have similar survival outcomes than those with concordant AS after undergoing TAVR.
- Aortic Valve (TAVR/TAVI)· Giornale italiano di cardiologia (2006)[Ventricular tachycardia and left bundle branch block after transcatheter aortic valve implantation: is the valve guilty forever or not?].
- Aortic Valve (TAVR/TAVI)· CureusAssociation of Comorbidity Burden With In-Hospital Mortality in Transcatheter Aortic Valve Replacement Patients With Coexisting Malignancy in the United States: A Retrospective Cohort Study.
- Aortic Valve (TAVR/TAVI)· Structural heart : the journal of the Heart TeamOutcomes of Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis of Observational Studies.
- Mitral Valve (Repair & Replacement)· Cardiovascular intervention and therapeuticsUse of TriClip steerable guide catheter for MitraClip: from bench to case.
- Mitral Valve (Repair & Replacement)· JACC. Cardiovascular interventionsPercutaneous Annuloplasty Followed by TEER for Tricuspid Regurgitation: A Multicenter Experience.
- Mitral Valve (Repair & Replacement)· JACC. Cardiovascular interventionsImpact of Coronary Artery Disease and Revascularization on Outcomes After Transcatheter Tricuspid Edge-to-Edge Repair.
